You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利生物(603718.SH):正式獲得香港藥明海德30%的股份
格隆匯 04-22 17:30

格隆匯4月22日丨海利生物(603718.SH)公佈,公司於2019年8月29日召開公司第三屆董事會第十四次會議,審議通過了《關於投資藥明海德香港有限公司的的議案》,同意授權經營層簽署相關投資協議並辦理涉及的相關手續,公司擬通過受讓股權以及增資的形式,總計現金投資4200萬美元,持有藥明海德香港有限公司(以下簡稱香港藥明海德)30%的股權。

近日,公司收到香港藥明海德的通知,香港藥明海德於2020年4月16日在香港特別行政區公司註冊處(Companies Registry.HK)完成了股權轉讓和董事變更的備案登記,公司正式獲得香港藥明海德30%的股份,同時增補公司董事長張海明為香港藥明海德董事。

截至目前,公司已經完成了有關增資手續的ODI(對外直接投資)批准,將會根據香港藥明海德的投資進展,逐步履行增資義務,後續公司也將持續關注本次投資的後續進展,並及時履行相關信息披露義務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account